ETTX insider filings

Entasis Therapeutics Holdings Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-07-13. Screen ETTX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ETTX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Entasis Therapeutics Holdings Inc.

FiledFormInsiderReported transactionsSource
2022-07-134Innoviva, Inc. — 10% owner
Innoviva Strategic Opportunities LLC
Purchase (P): 11,671,662 @ $2.20 · Purchase (P): 7,598,814 @ $2.20EDGAR
2022-07-114Wagner Kristie Ann — VP, Principal Fin & Acct OffDisposition to issuer (D): 80,500 · Other (J): 73,400 (derivative) @ $0EDGAR
2022-07-114Triola Anna Diaz — Chief Commercial OfficerDisposition to issuer (D): 125,000 · Other (J): 100,000 (derivative) @ $0EDGAR
2022-07-114Tommasi Ruben — Chief Scientific OfficerCode (U): 39,596 @ $2.20 · Disposition to issuer (D): 150,000 · Other (J): 98,700 (derivative) @ $0 · Other (J): 50,000 (derivative) @ $0 · Other (J): 24,858 (derivative) @ $0 · Other (J): 6,465 (derivative) @ $0EDGAR
2022-07-114Ronsheim Matthew — Chief of Pharma Sciences & MFGCode (U): 17,572 @ $2.20 · Disposition to issuer (D): 150,000 · Other (J): 33,333 (derivative) @ $0 · Other (J): 20,000 (derivative) @ $0 · Other (J): 15,000 (derivative) @ $0 · Other (J): 20,000 (derivative) @ $0EDGAR
2022-07-114Perros Manoussos — President and CEO, DirectorCode (U): 56,072 @ $2.20 · Disposition to issuer (D): 478,500 · Other (J): 325,755 (derivative) @ $0 · Other (J): 145,000 (derivative) @ $0 · Other (J): 183,013 (derivative) @ $0 · Other (J): 69,970 (derivative) @ $0EDGAR
2022-07-114Mueller John Patrick — Chief Development OfficerCode (U): 17,092 @ $2.20 · Disposition to issuer (D): 150,000 · Other (J): 75,698 (derivative) @ $0 · Other (J): 50,000 (derivative) @ $0 · Other (J): 25,092 (derivative) @ $0 · Other (J): 18,253 (derivative) @ $0EDGAR
2022-07-114Berger Heather A. — DirectorCode (U): 22,000 @ $2.20 · Disposition to issuer (D): 27,500 @ $2.20 · Other (J): 17,307 (derivative) @ $0 · Other (J): 11,000 (derivative) @ $0EDGAR
2022-07-114Altarac David — Chief Medical OfficerCode (U): 17,572 @ $2.20 · Disposition to issuer (D): 150,000 · Other (J): 92,307 (derivative) @ $0 · Other (J): 50,000 (derivative) @ $0EDGAR
2022-07-114Mayer Howard — DirectorCode (U): 22,000 @ $2.20 · Disposition to issuer (D): 27,500 @ $2.20 · Other (J): 12,500 (derivative) @ $0 · Other (J): 11,000 (derivative) @ $0EDGAR
2022-07-114Keiley Elizabeth M — General CounselCode (U): 17,572 @ $2.20 · Disposition to issuer (D): 150,000 · Other (J): 20,833 (derivative) @ $0 · Other (J): 50,000 (derivative) @ $0EDGAR
2022-07-114Meek David D. — DirectorCode (U): 22,000 @ $2.20 · Disposition to issuer (D): 27,500 @ $2.20 · Other (J): 17,307 (derivative) @ $0 · Other (J): 11,000 (derivative) @ $0EDGAR
2022-07-114HASTINGS DAVID C — DirectorCode (U): 22,000 @ $2.20 · Disposition to issuer (D): 27,500 @ $2.20 · Other (J): 26,583 (derivative) @ $0 · Other (J): 11,000 (derivative) @ $0EDGAR
2022-02-254Wagner Kristie Ann — VP, Principal Fin & Acct OffGrant/award (A): 10,000 @ $0EDGAR
2022-02-234Innoviva, Inc. — 10% owner
Innoviva Strategic Opportunities LLC — Director, 10% owner
Other (J): 0 (derivative) · Other (J): 0 (derivative)EDGAR
2022-02-154Mueller John Patrick — Chief Development OfficerDisposition to issuer (D): 22,816 (derivative) · Grant/award (A): 15,210 (derivative) · Disposition to issuer (D): 16,892 (derivative) · Grant/award (A): 12,993 (derivative) · Disposition to issuer (D): 7,265 (derivative) · Grant/award (A): 4,035 (derivative) · +2 moreEDGAR
2022-02-154Tommasi Ruben — Chief Scientific OfficerDisposition to issuer (D): 22,816 (derivative) · Grant/award (A): 15,210 (derivative) · Disposition to issuer (D): 15,632 (derivative) · Grant/award (A): 12,024 (derivative) · Disposition to issuer (D): 50,411 (derivative) · Grant/award (A): 28,006 (derivative) · +2 moreEDGAR
2022-02-154Ronsheim Matthew — See RemarksDisposition to issuer (D): 40,000 (derivative) · Grant/award (A): 33,333 (derivative)EDGAR
2022-02-154Perros Manoussos — President and CEODisposition to issuer (D): 87,462 (derivative) · Grant/award (A): 58,307 (derivative) · Disposition to issuer (D): 166,623 (derivative) · Grant/award (A): 128,531 (derivative) · Disposition to issuer (D): 79,698 (derivative) · Grant/award (A): 44,276 (derivative) · +2 moreEDGAR
2022-02-154Behanna Heather — DirectorDisposition to issuer (D): 15,000 (derivative) · Grant/award (A): 11,538 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Grant/award (A): 5,769 (derivative)EDGAR
2022-02-154Altarac David — Chief Medical OfficerDisposition to issuer (D): 120,000 (derivative) · Grant/award (A): 92.31 (derivative)EDGAR
2022-02-154Mayer Howard — DirectorDisposition to issuer (D): 15,000 (derivative) · Grant/award (A): 12,500 (derivative)EDGAR
2022-02-154Gutch Michael — See RemarksDisposition to issuer (D): 30,006 (derivative) · Grant/award (A): 23,081 (derivative) · Disposition to issuer (D): 15,956 (derivative) · Grant/award (A): 8,863 (derivative) · Disposition to issuer (D): 56,500 (derivative) · Grant/award (A): 43,460 (derivative)EDGAR
2022-02-154Keiley Elizabeth M — General CounselDisposition to issuer (D): 25,000 (derivative) · Grant/award (A): 20,833 (derivative)EDGAR
2022-02-154Meek David D. — DirectorDisposition to issuer (D): 15,000 (derivative) · Grant/award (A): 11,538 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Grant/award (A): 5,769 (derivative)EDGAR
2022-02-154HASTINGS DAVID C — DirectorDisposition to issuer (D): 12,060 (derivative) · Grant/award (A): 9,276 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Grant/award (A): 11,538 (derivative) · Disposition to issuer (D): 7,500 (derivative) · Grant/award (A): 5,769 (derivative)EDGAR
2022-01-194Tommasi Ruben — Chief Scientific OfficerGrant/award (A): 125,000 @ $0EDGAR
2022-01-194Ronsheim Matthew — See RemarksGrant/award (A): 125,000 @ $0EDGAR
2022-01-194Perros Manoussos — See RemarksGrant/award (A): 125,000 @ $0EDGAR
2022-01-194Mueller John Patrick — Chief Development OfficerGrant/award (A): 125,000 @ $0EDGAR
2022-01-194Behanna Heather — DirectorGrant/award (A): 27,500 @ $0EDGAR
2022-01-194Altarac David — Chief Medical OfficerGrant/award (A): 125,000 @ $0EDGAR
2022-01-194Triola Anna Diaz — Chief Commercial OfficerGrant/award (A): 125,000 @ $0EDGAR
2022-01-194Mayer Howard — DirectorGrant/award (A): 27,500 @ $0EDGAR
2022-01-194Gutch Michael — See RemarksGrant/award (A): 125,000 @ $0EDGAR
2022-01-194Keiley Elizabeth M — General CounselGrant/award (A): 125,000 @ $0EDGAR
2022-01-194Meek David D. — DirectorGrant/award (A): 27,500 @ $0EDGAR
2022-01-194HASTINGS DAVID C — DirectorGrant/award (A): 27,500 @ $0EDGAR
2021-11-034Ronsheim Matthew — Chief, Pharma Sciences & MFG.Tax withholding (F): 3,669 @ $2.94EDGAR
2021-11-034Altarac David — Chief Medical OfficerTax withholding (F): 3,669 @ $2.94EDGAR
2021-11-034Mueller John Patrick — Chief Development OfficerTax withholding (F): 3,907 @ $2.94EDGAR
2021-11-034Perros Manoussos — President and CEO, DirectorTax withholding (F): 11,704 @ $2.94EDGAR
2021-11-034Tommasi Ruben — Chief Scientific OfficerTax withholding (F): 3,669 @ $2.94EDGAR
2021-11-034Gutch Michael — CFO and Chief Business OfficerTax withholding (F): 3,669 @ $2.94EDGAR
2021-11-034Keiley Elizabeth M — General CounselTax withholding (F): 3,669 @ $2.94EDGAR
2021-10-204Mueller John Patrick — Chief Development OfficerGrant/award (A): 25,000 @ $0 · Sale (S): 4,001 @ $3.19EDGAR
2021-10-204Tommasi Ruben — Chief Scientific OfficerGrant/award (A): 25,000 @ $0 · Sale (S): 3,759 @ $3.19EDGAR
2021-10-204Altarac David — Chief Medical OfficerGrant/award (A): 25,000 @ $0 · Sale (S): 3,759 @ $3.19EDGAR
2021-10-204Ronsheim Matthew — See RemarksGrant/award (A): 25,000 @ $0 · Sale (S): 3,759 @ $3.19EDGAR
2021-10-204Gutch Michael — See RemarksGrant/award (A): 25,000 @ $0 · Sale (S): 3,759 @ $3.19EDGAR

Recent 8-K events — Entasis Therapeutics Holdings Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2022-07-118-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2022-05-238-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-04-278-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-038-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-02-258-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2022-02-188-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
3.02 — Unregistered Sales of Equity Securities
3.03 — Material Modification to Rights of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2022-01-148-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2021-11-128-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2021-11-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-10-198-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ETTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs